Home › Acute Lymphoblastic Leukemia › District of Columbia
Acute Lymphoblastic Leukemia clinical trials in District of Columbia
10 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Children's National Medical Center, Washington D.C.
Recruiting
Ages 1 to 25 · All sexes · Updated Oct 5, 2026 · NCT05621291Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Children's National Hospital, Washington D.C.
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Massage Impact on Sleep in Pediatric Oncology
- Children's National Hospital, Washington D.C.
Recruiting
Ages 12 to 21 · All sexes · Updated Apr 15, 2026 · NCT06892158A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555Feasibility/Acceptability of Attentional-Control Training in Survivors
- Children's National Hospital, Washington D.C.
Recruiting
Ages 8 to 16 · All sexes · Updated Jan 10, 2025 · NCT05528939Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
- Children's National Hospital, Washington D.C.
Recruiting
Ages 7 and older · All sexes · Updated Dec 9, 2024 · NCT06722638Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.